CLPTM1L and pancreatic neoplasm: In pancreatic cancer, the UPR sensor GRP78 interacts with the extracellular domain of calcium phosphate binding protein 1-like (CLPTM1L)/cisplatin resistance-related protein 9 (CRR9), facilitating the development of chemoresistance185.